妇科恶性肿瘤女性治疗与死亡率随时间变化的种族和民族差异
利用美国国家癌症数据库(2004-2014)分析子宫内膜癌、卵巢癌、宫颈癌和外阴癌女性接受循证实践的趋势,并用监测、流行病学和最终结果计划(2000-2009)数据分析5年生存趋势。研究发现黑人、西班牙裔等少数族裔在多个癌种中接受淋巴结清扫、手术联合化疗、放化疗等循证治疗的比例低于白人及亚裔,黑人女性卵巢癌、子宫内膜癌和宫颈癌的5年生存率较低。结论认为循证治疗实施中的种族差异持续存在,黑人女性癌症特异性死亡率持续较高。
要点
- 黑人(64.8%)和西班牙裔(68.3%)Ⅰ期卵巢癌患者接受淋巴结清扫比例低于亚裔(79.5%)和白人(74.6%)。
- Ⅱ-Ⅳ期卵巢癌中白人及亚裔76.6%接受手术联合化疗,黑人70.8%、西班牙裔73.9%。
- 黑人女性宫颈癌(75.6% vs 80.4%)和外阴癌(58.8% vs 63.5%)接受循证治疗比例低于其他组。
核心结论
- 循证治疗实施中的显著种族差异持续存在。
- 黑人卵巢癌、子宫内膜癌和宫颈癌女性癌症特异性死亡率持续高于其他组。
研究设计与样本
- 利用美国国家癌症数据库(2004-2014)识别诊断为子宫内膜癌、卵巢癌、宫颈癌和外阴癌的女性,分析各癌种接受循证实践的趋势。
- 利用监测、流行病学和最终结果计划(2000-2009)数据分析5年生存趋势。
主要发现
- 整个研究期间黑人(64.8%)和西班牙裔(68.3%)Ⅰ期卵巢癌女性接受淋巴结清扫比例低于亚裔(79.5%)和白人(74.6%)。
- 黑人女性在所有时期接受淋巴结清扫的比例均为最低组。
- Ⅱ-Ⅳ期卵巢癌中白人及亚裔76.6%接受手术联合化疗,黑人70.8%、西班牙裔73.9%。
- 西班牙裔深部浸润或高级别Ⅰ期子宫内膜癌女性接受淋巴结清扫比例(74.5%)低于所有其他组(80.7%)。
- 黑人ⅡB-ⅣA期宫颈癌女性接受放化疗比例(75.6%)低于所有其他组(80.4%),接受外阴癌手术淋巴结评估比例(58.8%)低于所有其他组(63.5%)。
关键数值与推荐
- 循证实践依据专业学会推荐定义。
- 黑人卵巢癌、子宫内膜癌和宫颈癌女性5年生存率低于其他组。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To examine temporal trends in treatment and survival among black, Asian, Hispanic, and white women diagnosed with endometrial, ovarian, cervical, and vulvar cancer. METHODS: Using the National Cancer Database (2004-2014), we identified women diagnosed with endometrial, ovarian, cervical, and vulvar cancer. For each disease site, we analyzed race/ethnicity-specific trends in receipt of evidence-based practices. Professional societies' recommendations were used to define these practices. Using data from the Surveillance, Epidemiology, and End Results Program (2000-2009) we analyzed trends in 5-year survival. RESULTS: Throughout the study period black (64.8%) and Hispanic (68.3%) women were less likely to undergo lymphadenectomy for stage I ovarian cancer compared to Asian (79.5%) and white patients (74.6%). Black women were the least likely group to undergo lymphadenectomy in all periods. Among patients with stage II-IV ovarian cancer, 76.6% of white and Asian women received both surgery and chemotherapy, compared to 70.8% of black and 73.9% Hispanic women. Hispanic women with deeply invasive or high-grade stage I endometrial cancer underwent lymphadenectomy less frequently (74.5%) than all other groups (80.7%). Black women were less likely to have chemo-radiotherapy for stage IIB-IVA cervical cancer (75.6% versus 80.4% of all others). Black women were also less likely to have a surgical lymph node evaluation for vulvar cancer (58.8% versus 63.5% of all others). Among women diagnosed with ovarian, endometrial, and cervical cancer, black women had lower five-year survival than other groups. CONCLUSION: Significant racial disparities persist in the delivery of evidence-based care. Black women with ovarian, endometrial, and cervical cancer continue to experience higher cancer-specific mortality than other groups.
引用
- Rauh-Hain JA, Melamed A, Schaps D, et al. Racial and ethnic disparities over time in the treatment and mortality of women with gynecological malignancies. Gynecol Oncol. 2018. PMID: 29605048. doi:10.1016/j.ygyno.2017.12.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。